Global Healthcare Nanotechnology Revenue Is Nearly 146.8 Billion USD In 2017
Friday, 15 Nov, 2019
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

In the last several years, global market of Healthcare Nanotechnology developed rapidly, with an average growth rate of 9.82% during 2013 to 2018. In 2017, global revenue of Healthcare Nanotechnology is nearly 146.8 Billion USD.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017. 

Healthcare Nanotechnology is widely used for Anticancer, CNS?Product, Anti-infective and other field. The most proportion of Healthcare Nanotechnology is used for CNS Product, and the proportion in 2017 is 21%.

North America is largest consumption place, with a consumption market share nearly 44.9% in 2017. 

Market competition is not intense. Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.